• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[工业化国家百日咳的流行病学]

[Epidemiology of pertussis in industrialized countries].

作者信息

Baron S, Bégué P, Grimprel E

机构信息

Réseau national de santé publique, hôpital de Saint-Maurice, France.

出版信息

Sante. 1994 May-Jun;4(3):195-200.

PMID:7921686
Abstract

Pertussis remains present in the industrialized world, although the widespread use of whole-cell pertussis vaccine has led to a dramatic decline of the disease. Great differences in immunization policies and coverage explain the uneven epidemiological pattern across the developed world. Different situations can be described. In some countries such as Japan, UK and Italy, concerns about the occurrence of severe adverse events following pertussis vaccination in the 70's led to a reduced acceptance and thus, to a significant decrease in immunization coverage. In Sweden, the protective efficacy of pertussis vaccine was questioned and vaccination was discontinued in 1979. In all these countries, severe epidemics of pertussis were observed in the following years, and immunization was then reinforced in some (UK). In Japan, considerable efforts were made to develop new and safer pertussis acellular vaccines which have replaced the whole-cell vaccine since 1981. In other countries such as the USA and France, despite a continuous immunization programme maintaining a sustained and high coverage, a resurgence of the disease was observed in association with a modification of the age-distribution. Vaccinated adults became susceptible to the infection because of progressive waning, vaccine-induced immunity. These patients contaminated very young and thus, unvaccinated infants. These observations underline the need for early immunization in infants as well as the importance of late booster doses to be given to older children or adults.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

百日咳在工业化国家仍然存在,尽管全细胞百日咳疫苗的广泛使用已使该疾病大幅减少。免疫政策和覆盖率的巨大差异解释了发达国家中不均衡的流行病学模式。可以描述不同的情况。在一些国家,如日本、英国和意大利,对20世纪70年代百日咳疫苗接种后发生严重不良事件的担忧导致疫苗接受度降低,进而免疫覆盖率显著下降。在瑞典,百日咳疫苗的保护效力受到质疑,1979年停止了疫苗接种。在所有这些国家,随后几年都观察到了严重的百日咳疫情,之后一些国家(如英国)加强了免疫接种。在日本,人们大力研发新的、更安全的无细胞百日咳疫苗,自1981年以来,这些疫苗已取代了全细胞疫苗。在其他国家,如美国和法国,尽管持续的免疫计划保持了较高且稳定的覆盖率,但随着年龄分布的变化,仍观察到了疾病的复发。由于疫苗诱导的免疫力逐渐减弱,接种过疫苗的成年人变得易受感染。这些患者感染了非常年幼、因此未接种疫苗的婴儿。这些观察结果强调了婴儿早期免疫的必要性以及对大龄儿童或成年人进行后期加强剂量接种的重要性。(摘要截选至250词)

相似文献

1
[Epidemiology of pertussis in industrialized countries].[工业化国家百日咳的流行病学]
Sante. 1994 May-Jun;4(3):195-200.
2
Control of pertussis in the world.全球百日咳的防控
World Health Stat Q. 1992;45(2-3):238-47.
3
[Can we control pertussis better? I. Changes in the epidemiology of pertussis].
Przegl Epidemiol. 1997;51(3):275-84.
4
Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.全细胞和无细胞百日咳疫苗接种计划以及婴幼儿百日咳发病率
CMAJ. 2006 Nov 7;175(10):1213-7. doi: 10.1503/cmaj.051637.
5
Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.1998 - 2001年美国6至59个月大儿童的百日咳疫苗效力
Pediatrics. 2005 Aug;116(2):e285-94. doi: 10.1542/peds.2004-2759.
6
[Time for booster doses against whooping cough for 10-year-old children].[10岁儿童百日咳加强针接种时间]
Lakartidningen. 2005;102(35):2394-8.
7
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.对瑞典在3、5和12月龄接种无细胞百日咳疫苗的儿童进行长期随访表明,5至7岁时需要加强一剂疫苗。
Pediatrics. 2006 Sep;118(3):978-84. doi: 10.1542/peds.2005-2746.
8
[Pertussis: a reemerging infection?].[百日咳:一种再度出现的感染性疾病?]
Epidemiol Mikrobiol Imunol. 2007 Apr;56(2):51-65.
9
Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.日本白喉类毒素-破伤风类毒素-无细胞百日咳疫苗的使用经验。
Clin Infect Dis. 1999 Jun;28 Suppl 2:S124-30. doi: 10.1086/515063.
10
[Can we control pertussis better? II. Old and new vaccines against pertussis].[我们能更好地控制百日咳吗?II. 新旧百日咳疫苗]
Przegl Epidemiol. 1997;51(3):285-95.

引用本文的文献

1
[Booster doses outside of the Expanded Program on Immunization in two schools in basic education in Yaounde, Cameroon].[喀麦隆雅温得两所基础教育学校免疫规划扩大项目之外的加强剂量]
Pan Afr Med J. 2011;10:20. Epub 2011 Oct 12.
2
Which strategy for pertussis vaccination today?如今百日咳疫苗接种采用哪种策略?
Paediatr Drugs. 2002;4(5):299-313. doi: 10.2165/00128072-200204050-00003.